Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2025-12-25 @ 5:35 PM
NCT ID:
NCT03099304
Group ID:
EG002
Title:
Ruxolitinib Cream 0.5% QD
Description:
All participants who received at least one dose of ruxolitinib cream 0.5% QD. Treatment was received by participants for 52 weeks in the combined vehicle-controlled and continued double-blind periods, and by those participants who were randomized to the vehicle group or were randomized to ruxolitinib cream 0.15% QD and did not achieve 25% improvement in F-VASI score at Week 24 and crossed over to 0.5% QD for 28 weeks (Week 24 to Week 52 \[continued double-blind treatment period\]).
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
45
Other Number Affected:
23
Other Number At Risk:
45
Study:
NCT03099304
Results Section:
NCT03099304
Adverse Events Module:
NCT03099304